KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to -$152.6 million.

  • Charles River Laboratories International's Cash from Financing Activities rose 26.46% to -$152.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$560.7 million, marking a year-over-year decrease of 59.54%. This contributed to the annual value of -$550.9 million for FY2024, which is 544.20% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Cash from Financing Activities stood at -$152.6 million, which was up 32.74% from -$226.9 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Cash from Financing Activities high stood at $518.0 million for Q2 2021, and its period low was -$285.9 million during Q2 2024.
  • Its 3-year average for Cash from Financing Activities is -$101.9 million, with a median of -$105.3 million in 2025.
  • Per our database at Business Quant, Charles River Laboratories International's Cash from Financing Activities surged by 597.57% in 2021 and then tumbled by 674.10% in 2025.
  • Charles River Laboratories International's Cash from Financing Activities (Quarterly) stood at -$219.0 million in 2021, then decreased by 13.69% to -$249.0 million in 2022, then skyrocketed by 149.63% to $123.6 million in 2023, then slumped by 161.41% to -$75.9 million in 2024, then climbed by 26.46% to -$152.6 million in 2025.
  • Its Cash from Financing Activities stands at -$152.6 million for Q3 2025, versus -$226.9 million for Q2 2025 and -$105.3 million for Q1 2025.